Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hematologic Diseases × Immunotherapy, Adoptive × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Lymphoma, Large B-Cell, Diffuse 12 Lymphoma, B-Cell 12 Lymphoma, Non-Hodgkin 11 Recurrence 9 Burkitt Lymphoma 8 Lymphoma 7 Multiple Myeloma 6 Neoplasms 5 Lymphoma, Mantle-Cell 5 Leukemia, Myeloid, Acute 5 Leukemia 5 Pancreatic Neoplasms 4 Lymphoma, Follicular 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Hematologic Neoplasms 4 Carcinoma, Hepatocellular 4 Nasopharyngeal Carcinoma 3 Leukemia, B-Cell 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Stomach Neoplasms 2 Simpson-Golabi-Behmel syndrome 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Osteosarcoma 2 Neoplasm, Residual 2 Melanoma 2 Lymphoma, B-Cell, Marginal Zone 2 Glioma 2

Interventions

fludarabine 11 Cyclophosphamide 10 Busulfan 8 Mycophenolic Acid 6 fludarabine phosphate 5 Whole-Body Irradiation 5 Tacrolimus 5 Melphalan 5 Dexamethasone 5 Granulocyte Colony-Stimulating Factor 4 Thiotepa 3 Sirolimus 3 Rituximab 3 Methotrexate 3 Cyclosporine 3 Blood Specimen Collection 3 Alemtuzumab 3 pomalidomide 2 pembrolizumab 2 isatuximab 2 Vorinostat 2 Stem Cell Transplantation 2 Platelet Transfusion 2 Lenalidomide 2 Interviews as Topic 2 Filgrastim 2 Etoposide 2 Carmustine 2 Bortezomib 2 Bone Marrow Transplantation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04180059 2026-01-26

CTL-DP 01

Nantes University Hospital

Phase 1 Recruiting

Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡